Rejuran Healer, explained.
Facial wrinkles: confirm the exact PN product and intended purpose. Explore the mechanism, limits, risks and recovery evidence before a real consultation.
Example medical information · Primary sources checked 2026-09-28 · No clinical reviewer assigned
How it works and what to discuss
The manufacturer describes REJURAN, a polynucleotide (PN) injectable, for temporary improvement of facial wrinkles. Confirm the exact product and intended use with a clinician.
Sources: PharmaResearch REJURAN product listing · Checked 2026-09-28
Suitability and limits
PN and PDRN are different product descriptions. Broad regeneration or scar-removal claims are not established here. The manufacturer listing does not establish current Korean authorization or individual suitability.
Sources: PharmaResearch REJURAN product listing · Checked 2026-09-28
Risks to understand
The reviewed manufacturer pages do not provide a complete patient safety leaflet. Product-specific safety remains unverified here. Ask about injection risks, contraindications and symptoms requiring medical attention before deciding.
Sources: PharmaResearch REJURAN product listing · Checked 2026-09-28
Recovery and follow-up
A product-specific recovery timeline has not been verified in this review. Request the current product leaflet and a written aftercare and follow-up plan.
Sources: PharmaResearch REJURAN product listing · Checked 2026-09-28
Understand the price basis.
Confirm the exact PN product, injected volume, area and follow-up. The 2 mL menu example is not a prescribed dose.
KRW 330,000 for 2 mL · one session, VAT included (example). A fixed fictional amount dated 2026-09-28; this is not a live quote or surveyed market price.
Check quote inclusionsPlanning a visit to Korea?
Confirm consultation, written aftercare and follow-up before committing your itinerary. No universal flight or recovery deadline is established here.
Read the visit-planning checklistWhat this research guide establishes.
Descriptions are bounded by the linked sources. They do not establish Korean authorization, a treatment recommendation or a result for you. This fictional site provides no clinical assessment. Product-specific labeling and a qualified clinician’s advice are needed.
Rejuran’s full patient safety leaflet and product-specific recovery remain unverified in this review. This gap must be resolved before presenting the guide as complete clinical information.